Betz Stephen F. — SEC Form 4 filings
SEC reporting owner CIK 1886575. 21 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2024-01-12 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 14 filings — 144,900 shares, $5,180,873 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: sale of 97,483 shares @ $32.23 ($3,141,877) in Crinetics Pharmaceuticals, Inc., filed 2025-06-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. (CRNX) | Chief Scientific Officer | 21 | — | 16 legs · 144,900 sh · $5,180,873 | 28 |
Form 4 filings — Betz Stephen F.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Disposition to issuer (D): 58,286 @ $85 · Disposition to issuer (D): 79,650 @ $85 · Disposition to issuer (D): 90,514 (derivative) @ $83.09 · Disposition to issuer (D): 74,540 (derivative) @ $75.72 · Disposition to issuer (D): 56,250 (derivative) @ $59.81 · Disposition to issuer (D): 60,000 (derivative) @ $62.39 · +7 more | EDGAR |
| 2026-03-18 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 6,371 @ $37.11 · Sale (S): 4,241 @ $37.77 | EDGAR |
| 2026-02-25 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 30,000 @ $0 · Grant/award (A): 47,000 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 18,000 @ $1.91 · Option exercise (M): 18,000 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 71,525 @ $1.91 · Option exercise (M): 16,645 @ $9.28 · Sale (S): 97,483 @ $32.23 · Option exercise (M): 71,525 (derivative) @ $0 · Option exercise (M): 16,645 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 5,479 @ $34.17 · Sale (S): 291 @ $34.83 | EDGAR |
| 2025-02-24 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 43,000 @ $0 · Grant/award (A): 65,000 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Option exercise (M): 2,331 @ $1.91 · Option exercise (M): 2,331 (derivative) @ $0 | EDGAR |
| 2024-09-12 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 1,035 @ $51.50 | EDGAR |
| 2024-08-28 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $53.19 | EDGAR |
| 2024-08-14 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $47.68 | EDGAR |
| 2024-07-26 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $53.43 | EDGAR |
| 2024-07-12 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $48.55 | EDGAR |
| 2024-06-26 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $45.37 | EDGAR |
| 2024-06-11 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $43.86 | EDGAR |
| 2024-05-30 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $47.49 | EDGAR |
| 2024-05-14 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $49.43 | EDGAR |
| 2024-03-20 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Tax withholding (F): 3,655 @ $38.14 | EDGAR |
| 2024-03-06 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Grant/award (A): 23,000 @ $0 · Grant/award (A): 87,000 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $37.26 | EDGAR |
| 2024-01-12 | 4 | Crinetics Pharmaceuticals, Inc. (CRNX) | Sale (S): 3,000 @ $37.65 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1886575 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →